Ben Afari, FCCA

Ben Afari, FCCA has over 30 years of work experience in finance and accounting. Ben'smost recent role is as the Group Finance Director at Liminal BioSciences, a position they have held since February 2023. Prior to this, they served as the Divisional Finance Director at Liminal BioSciences from November 2020 to February 2023. From 2017 to 2020, Ben worked as the Regional Controller for the UK and Benelux at Bio-Rad Laboratories. Before that, they were the Head of Financial Reporting for UK & Ireland at Merck Group, a multinational pharmaceutical and life sciences company, where they worked from 2010 to 2017. Ben also has experience in the biotech industry, having served as the Associate Director of Finance Europe at CV Therapeutics from 2006 to 2009. Earlier in their career, they held financial roles at Fournier Pharmaceuticals Ltd, Walford Meadows International, and Homecorp Ltd.

Ben Afari, FCCA, has a background in accountancy. Ben attended London South Bank University, where they studied accountancy. Prior to that, between 1981 and 1983, they attended Achimota Secondary School. Furthermore, they also attended Datus, Tema and St George's RC School, although the duration and field of study for these institutions are unspecified.

In addition to their education, Ben Afari has obtained the certification of Fellow from the Association of Chartered Certified Accountants (FCCA), although the specific date of when they obtained this certification is not provided. The institution granting the certification is the Association of Chartered Certified Accountants.